ATYR · All filings · Read this filing
What changed 10-Q
Item 2. Unregistered Sales of Equity Securities
2023-11-09 compared with 2023-08-09 · 1 added, 3 removed, 71 unchanged (5% of the section changed)
35 unchanged sentences
March 20, 2018
−Removed: aTyr Pharma, Inc.
−Removed: 2015 Stock Option and Incentive Plan, as amended
Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
27 unchanged sentences
aTyr Pharma, Inc.
−Removed: August 9, 2023
+Added: November 9, 2023
/s/ Sanjay S.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.